ATE188475T1 - Tricyclische pteridinone und ein verfahren zu deren herstellung - Google Patents
Tricyclische pteridinone und ein verfahren zu deren herstellungInfo
- Publication number
- ATE188475T1 ATE188475T1 AT90250279T AT90250279T ATE188475T1 AT E188475 T1 ATE188475 T1 AT E188475T1 AT 90250279 T AT90250279 T AT 90250279T AT 90250279 T AT90250279 T AT 90250279T AT E188475 T1 ATE188475 T1 AT E188475T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- pteridinones
- tricyclic
- compounds
- tricyclic pteridinones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43757489A | 1989-11-17 | 1989-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE188475T1 true ATE188475T1 (de) | 2000-01-15 |
Family
ID=23736999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90250279T ATE188475T1 (de) | 1989-11-17 | 1990-11-12 | Tricyclische pteridinone und ein verfahren zu deren herstellung |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0429149B1 (de) |
JP (1) | JP3026020B2 (de) |
AT (1) | ATE188475T1 (de) |
CA (1) | CA2029651C (de) |
DE (1) | DE69033414T2 (de) |
DK (1) | DK0429149T3 (de) |
ES (1) | ES2145733T3 (de) |
GR (1) | GR3033079T3 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602252A (en) * | 1989-11-17 | 1997-02-11 | Berlex Laboratories, Inc. | Tricyclic pteridinones and a process for their preparation |
US5854419A (en) * | 1989-11-17 | 1998-12-29 | Schering Aktiengesellschaft | Tricyclic pteridinones and a process for their preparation |
US6410726B1 (en) | 2000-01-12 | 2002-06-25 | Tularik Inc. | Arylsulfonic acid salts of pyrimidine-based antiviral |
CA2458699C (en) * | 2001-09-04 | 2010-10-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
US6806272B2 (en) | 2001-09-04 | 2004-10-19 | Boehringer Ingelheim Pharma Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
EP1312365A1 (de) * | 2001-11-20 | 2003-05-21 | Jenapharm GmbH & Co. KG | Pteridinone zur Behandlung der erektilen Dysfunktion |
US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
DE102004029784A1 (de) | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel |
DE102004033670A1 (de) | 2004-07-09 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel |
US7728134B2 (en) | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
US20060074088A1 (en) | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
US20060058311A1 (en) | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
US20060035903A1 (en) | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
EP1632493A1 (de) | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
EP1630163A1 (de) | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102004058337A1 (de) | 2004-12-02 | 2006-06-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten |
US7439358B2 (en) | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
TWI315304B (en) * | 2006-08-31 | 2009-10-01 | Univ Taipei Medical | Indoline-sulfonamides compounds |
US8329695B2 (en) | 2007-08-03 | 2012-12-11 | Boehringer Ingelheim International Gmbh | Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide |
US8541418B2 (en) * | 2009-12-23 | 2013-09-24 | Elan Pharmaceutical, Inc. | Inhibitors of polo-like kinase |
US9358233B2 (en) | 2010-11-29 | 2016-06-07 | Boehringer Ingelheim International Gmbh | Method for treating acute myeloid leukemia |
US9370535B2 (en) | 2011-05-17 | 2016-06-21 | Boehringer Ingelheim International Gmbh | Method for treatment of advanced solid tumors |
CN102408380B (zh) * | 2011-12-22 | 2014-04-16 | 浙江大学 | 5-氨基嘧啶硫酮类化合物及其制备方法 |
US20150031699A1 (en) | 2013-07-26 | 2015-01-29 | Boehringer Ingelheim International Gmbh | Treatment of myelodysplastic syndrome |
US9867831B2 (en) | 2014-10-01 | 2018-01-16 | Boehringer Ingelheim International Gmbh | Combination treatment of acute myeloid leukemia and myelodysplastic syndrome |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2940654A1 (de) * | 1979-10-06 | 1981-04-16 | Bayer Ag, 5090 Leverkusen | Dimeres keten der 1,2,,-triazol-3-carbonsaeure |
US4440929A (en) * | 1981-07-16 | 1984-04-03 | Usv Pharmaceutical Corporation | Imidazoquinoxaline compounds |
AU612331B2 (en) * | 1986-09-30 | 1991-07-11 | Ciba-Geigy Ag | 2-substituted-e-fused-(1,2,4)triazolo(1,5-c)pyrimidines pharmaceutical compositions |
-
1990
- 1990-11-09 CA CA002029651A patent/CA2029651C/en not_active Expired - Fee Related
- 1990-11-12 AT AT90250279T patent/ATE188475T1/de not_active IP Right Cessation
- 1990-11-12 ES ES90250279T patent/ES2145733T3/es not_active Expired - Lifetime
- 1990-11-12 EP EP90250279A patent/EP0429149B1/de not_active Expired - Lifetime
- 1990-11-12 DE DE69033414T patent/DE69033414T2/de not_active Expired - Fee Related
- 1990-11-12 DK DK90250279T patent/DK0429149T3/da active
- 1990-11-16 JP JP2312590A patent/JP3026020B2/ja not_active Expired - Fee Related
-
2000
- 2000-03-28 GR GR20000400768T patent/GR3033079T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3026020B2 (ja) | 2000-03-27 |
CA2029651C (en) | 2000-06-06 |
DE69033414T2 (de) | 2000-08-03 |
CA2029651A1 (en) | 1991-05-18 |
EP0429149A1 (de) | 1991-05-29 |
DE69033414D1 (de) | 2000-02-10 |
GR3033079T3 (en) | 2000-08-31 |
JPH03170482A (ja) | 1991-07-24 |
DK0429149T3 (da) | 2000-06-13 |
EP0429149B1 (de) | 2000-01-05 |
ES2145733T3 (es) | 2000-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE188475T1 (de) | Tricyclische pteridinone und ein verfahren zu deren herstellung | |
ATE126225T1 (de) | Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung. | |
DE69325262D1 (de) | Vinylen-azaindolderivate und verfahren zu ihrer herstellung | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
HU908367D0 (en) | Process for the production of compounds with improved quality | |
ATE163008T1 (de) | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
DE3382299D1 (de) | Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung. | |
FR2695387B1 (fr) | Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
DE69010022D1 (de) | Kristallines Lactittrihydrat, dieses enthaltende feste kristalline Mischung und ein Verfahren zu deren Herstellung. | |
ATE108440T1 (de) | Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
ES2057159T3 (es) | Procedimiento estereoespecifico para la preparacion de enantiomeros de la furo(3,4-c)piridina, compuestos asi obtenidos y composiciones terapeuticas a base de estos compuestos. | |
DE3864636D1 (de) | Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen. | |
HUT35680A (en) | Process for preparing purine derivatives | |
ATE18226T1 (de) | Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
DE69710909D1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
DE3781879D1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE3854266D1 (de) | Verfahren zur Modifizierung eines Molekularsiebes. | |
ATE58532T1 (de) | (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung. | |
ATE48276T1 (de) | 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
ATE189220T1 (de) | Verfahren zur herstellung von 7-(3-amino- sowie 3-aminomethyl-1-pyrrolidinyl)-3-chinolon- carbonsäuren sowie -naphthyridoncarbonsäuren | |
MY103368A (en) | 1,3-dioxanes | |
DE3777464D1 (de) | Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung. | |
HUT49125A (en) | Process for producing new 2-thiazolidinone derivatives and pharmaceutical compositions containing them | |
ATE107631T1 (de) | Verfahren zur herstellung von indolinon-2- derivaten. | |
DE3672628D1 (de) | Hydantoin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |